Veracyte (VCYT) Tops Q2 EPS by 9c

Veracyte (NASDAQ: VCYT) reported Q2 EPS of ($0.13), $0.09 better than the analyst estimate of ($0.22). Revenue for the quarter came in at $72.9 million versus the consensus estimate of $68.08 million.

For earnings history and earnings-related data on Veracyte (VCYT) click here.

You May Also Be Interested In

• Mizuho says ignore Apple noise, flags key catalyst for Micron and memory in H2
• Tesla Q2 deliveries: What to expect from the critical report
• SanDisk (SNDK) PT Raised to $3,000 at Bernstein SocGen Group, 'We believe this is not understood by the Street'